Predict your next investment

Venture Capital
hedaventures.com

See what CB Insights has to offer

Investments

14

Funds

1

About HEDA Ventures

HEDA Ventures is an early stage venture capital firm that focuses on high-tech innovation areas, hence promoting industry upgrading and optimization of HEDA, creating an entrepreneur-friendly environment, and building a comprehensive service platform for high-tech start-ups in the zone. The company is also the strategy investment platform of the Group. HEDA Ventures is based in Silicon Valley and Hangzhou, China.

HEDA Ventures Headquarter Location

19 Davis Drive Suite 203

Belmont, California, 94004,

United States

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Latest HEDA Ventures News

Paragon Genomics Finds $8M In Series A

Sep 13, 2017

Haywards-based Paragon Genomics, a developer of next generation sequencing (NGS) technology, has raised $8M in a Series A funding. The funding was led by Cowin Venture Capital and Fosun Industrial Co., Limited, and also included Cloudstone Venture, HEDA Ventures, and Wisemont Capital…. Try Some Advice From 80,000 Hours People in the tech world like to talk about doing great things. But what does that actually mean for your career? If you’re serious about making a pos... Square’s Board Adds Former Brown University President Ruth Simmons Square announced a powerful addition to its board today — former Brown University President Ruth Simmons. Before her 11-year post at Brown, she was th... TapHeaven Promises True Automation For Mobile Advertisers The pitch for TapHeaven might sound a little familiar. Co-founder and CEO Chris Hoyt said his technology delivers truly automated ad-buying.What makes... Share this entry

HEDA Ventures Investments

14 Investments

HEDA Ventures has made 14 investments. Their latest investment was in Chance Pharmaceuticals as part of their Series C on October 10, 2021.

CBI Logo

HEDA Ventures Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

10/11/2021

Series C

Chance Pharmaceuticals

$30M

Yes

3

10/11/2021

Series C

Pulmed Pharma

$31M

Yes

China Merchants Securities Asset Management, Guozhong Venture Capital Management, and Lapam Capital

7

8/27/2021

Series B

Lynk Pharmaceuticals

$50M

Yes

26

4/16/2021

Series B

Subscribe to see more

$99M

Subscribe to see more

10

12/8/2020

Series D

Subscribe to see more

$99M

Subscribe to see more

10

Date

10/11/2021

10/11/2021

8/27/2021

4/16/2021

12/8/2020

Round

Series C

Series C

Series B

Series B

Series D

Company

Chance Pharmaceuticals

Pulmed Pharma

Lynk Pharmaceuticals

Subscribe to see more

Subscribe to see more

Amount

$30M

$31M

$50M

$99M

$99M

New?

Yes

Yes

Yes

Subscribe to see more

Subscribe to see more

Co-Investors

China Merchants Securities Asset Management, Guozhong Venture Capital Management, and Lapam Capital

Sources

3

7

26

10

10

HEDA Ventures Fund History

1 Fund History

HEDA Ventures has 1 fund, including Hangzhou Econ & Tech Dev Venture Capital Guidance Fund.

Closing Date

Fund

Fund Type

Status

Amount

Sources

Hangzhou Econ & Tech Dev Venture Capital Guidance Fund

Fund Of Funds

Open

1

Closing Date

Fund

Hangzhou Econ & Tech Dev Venture Capital Guidance Fund

Fund Type

Fund Of Funds

Status

Open

Amount

Sources

1

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.